Alivus Life Sciences Limited - Company Profile

Q: Who are the current directors of Alivus Life Sciences Limited?

The current directors of Alivus Life Sciences Limited are Yasir Yusufali Rawjee, Manju Agarwal, Vinod Naik, Kaushikbhai Nandubhai Patel, Hiren Karsanbhai Patel, Tushar Pravinchandra Mistry, Rudalf Joseph Corriea, Savan Rashmikant Godiawala, Taruvai Luxminarayanan Easwar.

It is a pharma public limited company based in Solapur, Maharashtra, India, established in 2011.

2011 Solapur, Maharashtra, India Active

Last Updated: January 09, 2026

Access Report

About Alivus Life Sciences Limited

Alivus Life Sciences Limited, a active public limited company, was established on 23 June 2011 in Solapur, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L74900PN2011PLC139963. Registered under ROC Roc Pune. it is listed on BSE: 543322 and NSE: GLS. It has an authorized capital of ₹46.00 Cr and a paid-up capital of ₹24.54 Cr.

Formerly known as Zorg Laboratories Private Limited, Glenmark Life Sciences Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹2,295.26 Cr and a net worth of ₹2,332.32 Cr. Employing 2,021 professional, Its leadership includes Yasir Yusufali Rawjee (Managing Director), Manju Agarwal (Director), Vinod Naik (Whole-Time Director). Past directors included Bhavesh Bansidhar Pujara, Yasir Yusufali Rawjee, Manju Agarwal. Its latest AGM occurred on 08 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 170-172 Chandramouli Industrial Estate, Mohol Ba, Zarpeth, Solapur, Maharashtra, 413213.

Company Details

CIN/LLPIN
L74900PN2011PLC139963
Registration Number
139963
Incorporation Date
23 June 2011
Authorized Capital
₹46.00 Cr
Paid-Up Capital
₹24.54 Cr
ROC Code
Roc Pune
Listing Status
Listed (BSE: 543322, NSE: GLS)
Company Status
Active

Key Metrics

Authorised Capital ₹ 46.00 Cr as on 09-01-2026
Paid Up Capital ₹ 24.54 Cr as on 09-01-2026
Company Age 14 Year, 7 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** 4.80% (FY 2024)
Profit Growth **** 0.84% (FY 2024)
Ebitda **** 4.97% (FY 2024)
Net Worth 9.08% (FY 2024)
Total Assets **** 5.49% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Alivus Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Alivus Life Sciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Yasir Yusufali Rawjee	Managing Director	26 Sep 2019	Current
Manju Agarwal	Director	08 Mar 2021	Current
Vinod Naik	Whole-Time Director	21 Oct 2022	Current
Kaushikbhai Nandubhai Patel	Director	06 Mar 2024	Current
Hiren Karsanbhai Patel	Director	06 Mar 2024	Current
Tushar Pravinchandra Mistry	Cfo	01 Jun 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Cfo	22 Apr 2022	Past
Pramod Abcsdd	Additional Director	26 Sep 2019	Past
Pramod Abcsdd	Additional Director	08 Mar 2021	Past
Pramod Abcsdd	Additional Director	07 Jul 2018	Past
Pramod Abcsdd	Additional Director	28 Sep 2020	Past
Pramod Abcsdd	Director	16 Jul 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Alivus Life Sciences.

Alivus Life Sciences Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 4.8% increase. The company also saw a slight improvement in profitability, with a 0.84% increase in profit. The company's net worth moved up by a moderate rise of 9.08%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

4.80%

*******

Revenue from Operations

*******

5.64%

*******

Total Assets

*******

5.49%

*******

Profit or Loss

*******

0.84%

*******

Net Worth

*******

9.08%

*******

EBITDA

*******

4.97%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Alivus Life Sciences?

In 2024, Alivus Life Sciences had a promoter holding of 82.85% and a public holding of 17.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Alivus Life Sciences?

Alivus Life Sciences has a workforce of 2021 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Alivus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alivus Life Sciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Alivus Life Sciences

Recent Activity within the Organization

Annual General Meeting

Progress on Alivus Life Sciences Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records. was documented.
08 Sep 2025
Balance Sheet

The activity Alivus Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.
31 Mar 2025
Director Appointment

The activity Savan Rashmikant Godiawala was appointed as a Director was appointed as a Director on 25 Apr 2024 & has been associated with this company since 1 year 9 months . was completed.
25 Apr 2024
Director Appointment

Progress on Kaushikbhai Nandubhai Patel was appointed as a Director was appointed as a Director on 06 Mar 2024 & has been associated with this company since 1 year 11 months . was documented.
06 Mar 2024
Director Appointment

The activity Hiren Karsanbhai Patel was appointed as a Director was appointed as a Director on 06 Mar 2024 & has been associated with this company since 1 year 11 months . was completed.
06 Mar 2024
Director Appointment

Vinod Naik was appointed as a Whole-time director was appointed as a Whole-time director on 21 Oct 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.
21 Oct 2022

Explore recent activity and updates - View Recent Activity